ST. PAUL, Minn., Nov. 13, 2014 /PRNewswire/ -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Greg S. Lea, EnteroMedics' Senior Vice President, Chief Financial Officer and Chief Operating Officer is scheduled to participate at the 2014 Canaccord Genuity Medical Technology and Diagnostics Forum. The event will be held on November 20, 2014 at 2:00 pm Eastern Time at the Westin Grand Central Hotel in New York, New York.
Mr. Lea will provide an overview of EnteroMedics and its VBLOC® vagal blocking therapy development and commercialization program.
The presentation will be webcast live and may be accessed by visiting EnteroMedics' website at www.enteromedics.com. A replay of the webcast will also be available immediately after the conclusion of the presentation for a period of ninety days. Investors can access the webcast under "Events" in the "Investors" section of EnteroMedics' website.
Institutional investors who wish to request a meeting with EnteroMedics should contact Canaccord Genuity.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.